The Trajectory of Physical Activity Following Pulmonary Rehabilitation
NCT ID: NCT02399254
Last Updated: 2019-08-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
21 participants
OBSERVATIONAL
2015-04-30
2017-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
NCT02600689
Pulmonary Rehabilitation in Patients Before Lung Transplantation (LTx)
NCT00962078
The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD
NCT02099799
Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD
NCT02725931
Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?
NCT02528487
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary Rehabilitation
Chronic Obstructive Pulmonary Disease (COPD) patients following pulmonary rehabilitation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. A post-bronchodilator forced expiratory volume in one second(FEV1)/forced vital capacity (FVC) \< 0.70 from spirometry performed within the preceding 12 months (no specific FEV1 percent-predicted requirement, although we anticipate the FEV1 will average around 45% of predicted, based on previous studies of pulmonary rehabilitation)
3. The patient was referred to pulmonary rehabilitation
4. The patient is clinically-stable: no exacerbation in preceding 4 weeks
5. Modified Medical Research Council (mMRC) dyspnea rating of at least 2 out of 5.
Exclusion Criteria
2. A significant movement disorder, such as hemiplegia, etc.
3. Inability to read and comprehend the questionnaires, which will be in English
4. A history of poor wound healing or chronic skin conditions that might predispose to local problems from wearing the DynaPort. (The DynaPort can be worn outside a thin garment, such as a tee shirt, and is relatively thin, without protruding parts. However, since the device may be worn overnight, and there is a remote risk of pressure problems, this exclusion criterion was added).
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Trinity Health Of New England
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard ZuWallack, MD
Role: PRINCIPAL_INVESTIGATOR
Saint Francis Hospital and Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
Gaylord Hospital
Wallingford, Connecticut, United States
VA Connecticut Research and Education Foundation
West Haven, Connecticut, United States
Ocean State Research Institute
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-06-001 E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.